Publication Date: 2023/07/06
Abstract: Objectives: To identify which Antisnake venom formulation is more effective, safe and cost effective on patients with snake bite. Method: The retrospective study was conducted at the Indus Hospital Badin, Pakistan, and comprised data of patients, with snake bite from 1st January to 31st December 2020 and patients were treated as per institutional protocol. Data was collected from Health management and information system (HMIS) software and analyzed using Statistical Package of social sciences (SPSS) 21. Results: Out of 159 patients, 124 patients were treated with Antisnake venom (Liquid) and 35 patients were with Antisnake venom (Powder). Total 441 vials of Antisnake venom (Powder) administered on 35 patients (12.6 vials per patient) and cost per patient estimated as 16,632 Pakistani rupees, furthermore hospital stay of patients with Antisnake venom (Powder) was 6-12 days and in the case of Antisnake venom (Liquid), total 512 vials used on 124 patients (4.12 vials per patient) and cost per patient estimated as 2,318.592 Pakistani rupees much less than patients treated with Antisnake venom (Powder). Conclusion: Antisnake venom (Liquid) is more effective, safe and cost-effective than Antisnake venom (Powder).
Keywords: Antisnake Venom, Snake Bite, Safe, Cost- Effective, Pakistan.
DOI: https://doi.org/10.5281/zenodo.8118847
PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT23JUN2309.pdf
REFERENCES